NASDAQ
GenSight Biologics S.A. (GSGTF) has a fcf yield of -38.23% as of Monday, August 3, 2026. This represents a 30.14% increase compared to its 12-month average of -54.73%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.